Andrew R Robbins
CIK 1590157 · President and CEO · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$22.80M
Companies
2
Total Filings
30
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | President and CEO | 657,503 | $34.68 | $22.80M | $0 | 9 | 2026-05-21 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Director | 0 | $23.01 | $0 | $0 | 7 | 2024-03-11 |
Recent Filings · Page 2 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-14 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-12 | COGT | Grant (A) | — | $0 | EDGAR |
| 2020-12-09 | COGT | Grant (A) | — | $0 | EDGAR |
| 2020-10-27 | COGT | Grant (A) | — | $0 | EDGAR |
| 2020-04-01 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-30 | — | Disp (D) | −201,564 | -$3.41M | |
| 2019-04-03 | — | Mixed | +11,028 | -$213.0K | |
| 2019-02-08 | — | Mixed | −114,626 | -$4.09M | |
| 2018-12-18 | — | Mixed | +15,153 | -$190.0K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.